Tofacitinib and Acitretin Capsules.
KY2025060
Approved small_molecule active
Quick answer
Tofacitinib and Acitretin Capsules. for Primary Cutaneous Amyloidosis is a Approved program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Primary Cutaneous Amyloidosis
- Phase
- Approved
- Modality
- small_molecule
- Status
- active